Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 17/3029% below fair value
$59.12−1.98 (-3.24%)
Close on Nov 16, 2026Market cap $1.71BP/E 17.2Yield –
Inspire Medical Systems profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Inspire Medical Systems's profit margin for the twelve months ending Sep 30, 2026 was 11.4%. For fiscal 2025 it was 15.9%, against 6.7% the year before. The highest annual figure on record is 15.9% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.9% | +9.3 |
| FY2024 | Dec 31, 2024 | 6.7% | +10.1 |
| FY2023 | Dec 31, 2023 | -3.4% | +7.6 |
| FY2022 | Dec 31, 2022 | -11.0% | +7.0 |
| FY2021 | Dec 31, 2021 | -18.0% | +31.6 |
| FY2020 | Dec 31, 2020 | -49.6% | −9.1 |
| FY2019 | Dec 31, 2019 | -40.5% | +2.6 |
| FY2018 | Dec 31, 2018 | -43.1% | +18.2 |
| FY2017 | Dec 31, 2017 | -61.3% | +51.5 |
| FY2016 | Dec 31, 2016 | -112.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -11.8% | −16.2 |
| Q2 FY2026 | Jun 30, 2026 | 0.2% | +1.8 |
| Q1 FY2026 | Mar 31, 2026 | -5.5% | −7.0 |
| Q4 FY2025 | Dec 31, 2025 | 50.6% | +35.9 |
| Q3 FY2025 | Sep 30, 2025 | 4.4% | −4.7 |
| Q2 FY2025 | Jun 30, 2025 | -1.7% | −6.7 |
| Q1 FY2025 | Mar 31, 2025 | 1.5% | +7.6 |
| Q4 FY2024 | Dec 31, 2024 | 14.7% | +7.0 |
| Q3 FY2024 | Sep 30, 2024 | 9.1% | +14.7 |
| Q2 FY2024 | Jun 30, 2024 | 5.0% | +12.9 |
| Q1 FY2024 | Mar 31, 2024 | -6.1% | +6.0 |
| Q4 FY2023 | Dec 31, 2023 | 7.7% | +5.4 |
| Q3 FY2023 | Sep 30, 2023 | -5.6% | +9.9 |
| Q2 FY2023 | Jun 30, 2023 | -7.9% | +7.9 |
| Q1 FY2023 | Mar 31, 2023 | -12.1% | +12.0 |
| Q4 FY2022 | Dec 31, 2022 | 2.3% | +5.3 |
| Q3 FY2022 | Sep 30, 2022 | -15.4% | +1.3 |
| Q2 FY2022 | Jun 30, 2022 | -15.9% | +8.9 |
| Q1 FY2022 | Mar 31, 2022 | -24.1% | +16.1 |
| Q4 FY2021 | Dec 31, 2021 | -3.0% | +13.2 |
| Q3 FY2021 | Sep 30, 2021 | -16.8% | +12.2 |
| Q2 FY2021 | Jun 30, 2021 | -24.7% | +164.8 |
| Q1 FY2021 | Mar 31, 2021 | -40.2% | +35.9 |
| Q4 FY2020 | Dec 31, 2020 | -16.3% | +17.5 |
| Q3 FY2020 | Sep 30, 2020 | -29.0% | +10.6 |
| Q2 FY2020 | Jun 30, 2020 | -189.5% | −147.1 |
| Q1 FY2020 | Mar 31, 2020 | -76.1% | −25.2 |
| Q4 FY2019 | Dec 31, 2019 | -33.7% | −4.9 |
| Q3 FY2019 | Sep 30, 2019 | -39.5% | −3.6 |
| Q2 FY2019 | Jun 30, 2019 | -42.4% | +11.1 |
| Q1 FY2019 | Mar 31, 2019 | -50.9% | +13.9 |
| Q4 FY2018 | Dec 31, 2018 | -28.9% | +13.8 |
| Q3 FY2018 | Sep 30, 2018 | -36.0% | +19.4 |
| Q2 FY2018 | Jun 30, 2018 | -53.5% | +25.2 |
| Q1 FY2018 | Mar 31, 2018 | -64.7% | +19.9 |
| Q4 FY2017 | Dec 31, 2017 | -42.7% | – |
| Q3 FY2017 | Sep 30, 2017 | -55.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -78.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -84.6% | – |
See a number that looks wrong?